Vaccine and mycostatin in treatment of cryptococcosis of the respiratory tract

References

• Abrahams I. Further studies on acquired resistance to murine cryptococcosis: enhancing effect of bordetella pertussis. The Journal of Immunology 1966; 96: 525–529
   PubMed Web of Science ®Google Scholar
• Akerman M. Personal communication. 1975
   Google Scholar
• Altman G. Personal communication. 1973
   Google Scholar
• Beemer A.M., Bubis S. Cresyl blue and cresyl blue plus Sudan III as stains for use in exfoliative and other cytology. Bulletin of The World Health Organization 1964; 31: 865–868
   PubMed Web of Science ®Google Scholar
• Beemer A.M., Jesiotr M., Levitt R., Kuttin E.S. Treatment of a refractory case of pulmonary tuberculosis with PPD. Harefuah 1972; 83: 427–428
   PubMedGoogle Scholar
• Beemer A.M., Jesiotr M., Kuttin E.S., Lavie G. Autogenous vaccine therapy in hemoptysis due to pulmonary aspergillosis. Harefuah 1971; 81: 330–331
   PubMedGoogle Scholar
• Beemer A.M., Kuttin E.S., Pinkenson M. Cytology for early diagnosis of cryptococcal Tracheo-bronchitis. Mykosen 1972; 15: 359–365
   PubMedGoogle Scholar
• Beemer A.M., Kuttin E.S., Zydon Y., Hecht B. Some observations of the incidence, importance and treatment of tinea pedis. Harefuah 1974; 87: 150–153
   PubMedGoogle Scholar
• Campbell G.D. Primary pulmonary Cryptococcosis. American Review of Respiratory Diseases 1966; 94: 236–243
   PubMed Web of Science ®Google Scholar
• Cockshott W.P. Radiological patterns of the deep mycoses. In Sytemic mycoses. A Ciba Foundation Symposium. commemoration of William Balfour Baikie, G.E.W. Wolstenholme, R.P. Porter. J. & A. Churchill LTS., London 1968; 118–119, In
   Google Scholar
• Conant H.F., Smith D.T., Baker R.D., Callaway J.L. Manual of Clinical MycologyThird edition. W.B. Saunders Company, Philadelphia London, Toronto 1971; 288–324
   Google Scholar
• Conant N.F., Smith D.T., Baker R.G., Callaway J.L., Martin D.S. Manual of Clinical MycologySecond edition. W. B. Saunders Company, Philadelphia & London 1954; 165–165
   Google Scholar
• Dresser D.W., Mitchison N.A. The Mechanism of Immunological Paralysis. Advances in Immunology, F.J. Dixon, H.G. Hunkel. Academic Press, New York and London 1968; 8: 129–181, in
   Google Scholar
• Drouhet R. The therapeutic use of antifungal agents in Fungus diseases and their treatment, R.W. Riddell, G.T. Stewart. Butterworth & Co. Ltd., London 1958; 202–202
   Google Scholar
• Emmons C.W., Binford C.H., Utz J.P. Medical MycologySecond edition. Lea & Febiger, Philadelphia 1971; 186–206
   Google Scholar
• Fegler F. Medizinische Mykologie in Praxis und Klinik. Springer-Verlag, Berlin, Heidelberg, New York 1967; 97–98
   Google Scholar
• Finkel M.J. Amphotericin B. Med. Use. The Merck Index of Chemicals and Drugs7th Edition. Merck & Co., Inc., Rahway, N.J.U.S.A. 1960; 73–73, In
   Google Scholar
• Gadebusch H.H. Mechanisms of native and acquired resistance to infection with Cryptococcus neoformans. Critical Reviews in Microbiology 1972; 1: 311–320
   Google Scholar
• Jesiotr M., Beemer A.M. Vaccine and antimicrobial therapy in pulmonary nocardiosis. Scandinavian Journal of Respiratory Diseases 1969; 50: 54–60
   PubMedGoogle Scholar
• Kimmig J. Moderne Erkenntnisse in der Behandlung der Pilzerkrankungen. Mykologische Fortbildung, E. Heinke, K.F. Schaller, H.P. Rieth. Schwarzeck Verlag, Muenchen 1973; 19–20, In
   Google Scholar
• Littman M.L., Zimmerman L.E. Cryptococcosis. Grune & Stratton, New York & London 1956; 3–16
   Google Scholar
• Manelis J., Reichenthal E., Merzbach D., Haschman N., Peyser E. Cryptococcus neoformans meningitis. Report of a case and review of cryptococcosis in Israel. Confinia Neurologica 1973; 35: 304–311
   PubMedGoogle Scholar
• Mohr W., Thiele G. Cryptococcose. Mykologische Fortbildung, E. Heinke, K.D. Schaller, H.P. Rieth. Schwarzeck Verlag, Muenchen 1973; 131–136, In
   Google Scholar
• Rippon J.W. Medical Mycology. W. B. Saunders Company, Philadelphia, London & Toronto 1974; 205–223
   Google Scholar
• Spencer H. Pathology of the lungSecond edition. Pergamon Press, Oxford, London, New York & Paris 1962; 325–325, 434, 659
   Google Scholar
• Schoenebeck J. 5-Fluorocytosine treatment of candidosis of the urinary tract and candida infection localised elsewhere. Proceedings of the 5th I.S.H.A.M. Congress, Paris. Institut Pasteur, 1971; 299–299, Edited by the the Comité d'Organisation, Drouhet, E.P.
   Google Scholar
• Tager A., Lass N., Avigad J., Beemer A.M. Immunotherapy of superficial dermatomycoses. Dermatologica 1973; 147: 123–129
   PubMedGoogle Scholar
• Thomson D., Thomson R., Morrison J.T. Oral vaccines and immunization by other unusual routes. H. & S. Livingstone Ltd., Edinburgh 1948
   Google Scholar
• Tynes B., Mason K.N., Jennings A.E., Bennett J.E. Variant forms of pulmonary cryptococcosis. Annals of Internal Medicine 1968; 69: 1117–1125
   PubMed Web of Science ®Google Scholar
• Utz J.P. Personal communication. 1975
   Google Scholar
• Utz J.P., Duma R.J., McGehee R.F., Warner J.F. Chemotherapy of the systemic mycoses: Recent Clinical Observations. Proceedings of the 5th I.S.H.A.M. Congress, Paris. Institut Pasteur, 1971; 295–295, In Edited by the Comité d'Organisation, Drouhet, E.P.
   Google Scholar
• Warr W., Bates J.H., Stone A. The spectrum of pulmonary cryptococcosis. Annals of Internal Medicine 1968; 69: 1109–1116
   PubMed Web of Science ®Google Scholar
• Weidman F.D. Tenth Annual Meeting of the Society for Investigative Dermatology. Atlantic City, N.J. June, 1949, 12
   Google Scholar
• Zajicek J. Personal communication. 1975
   Google Scholar